Anti-THNS2/ THNSL2/ SOFAT functional antibody
Anti-THNS2/ THNSL2/ SOFAT functional antibody for cell culture, ELISA & in-vivo assay
Go to THNSL2/THNSL2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE1337-Ab-1/ GM-Tg-hg-SE1337-Ab-2 | Anti-Human THNSL2 monoclonal antibody | Human |
GM-Tg-rg-SE1337-Ab-1/ GM-Tg-rg-SE1337-Ab-2 | Anti-Rat THNSL2 monoclonal antibody | Rat |
GM-Tg-mg-SE1337-Ab-1/ GM-Tg-mg-SE1337-Ab-2 | Anti-Mouse THNSL2 monoclonal antibody | Mouse |
GM-Tg-cynog-SE1337-Ab-1/ GM-Tg-cynog-SE1337-Ab-2 | Anti-Cynomolgus/ Rhesus macaque THNSL2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE1337-Ab-1/ GM-Tg-felg-SE1337-Ab-2 | Anti-Feline THNSL2 monoclonal antibody | Feline |
GM-Tg-cang-SE1337-Ab-1/ GM-Tg-cang-SE1337-Ab-2 | Anti-Canine THNSL2 monoclonal antibody | Canine |
GM-Tg-bovg-SE1337-Ab-1/ GM-Tg-bovg-SE1337-Ab-2 | Anti-Bovine THNSL2 monoclonal antibody | Bovine |
GM-Tg-equg-SE1337-Ab-1/ GM-Tg-equg-SE1337-Ab-2 | Anti-Equine THNSL2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE1337-Ab-1/ GM-Tg-hg-SE1337-Ab-2; GM-Tg-rg-SE1337-Ab-1/ GM-Tg-rg-SE1337-Ab-2; GM-Tg-mg-SE1337-Ab-1/ GM-Tg-mg-SE1337-Ab-2; GM-Tg-cynog-SE1337-Ab-1/ GM-Tg-cynog-SE1337-Ab-2; GM-Tg-felg-SE1337-Ab-1/ GM-Tg-felg-SE1337-Ab-2; GM-Tg-cang-SE1337-Ab-1/ GM-Tg-cang-SE1337-Ab-2; GM-Tg-bovg-SE1337-Ab-1/ GM-Tg-bovg-SE1337-Ab-2; GM-Tg-equg-SE1337-Ab-1/ GM-Tg-equg-SE1337-Ab-2 |
Products Name | Anti-THNSL2 monoclonal antibody |
Format | mab |
Target Name | THNSL2 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-THNSL2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE1337-Ag-1 | Recombinant multi-species THNS2/ THNSL2/ SOFAT protein |
Target information
Target ID | GM-SE1337 |
Target Name | THNSL2 |
Gene ID | 55258,232078,297332,699203,475757,101095735,541205,100066561 |
Gene Symbol and Synonyms | RGD1309144,SOFAT,THNSL2,THS2,TSH2 |
Uniprot Accession | Q86YJ6,Q5M7T9 |
Uniprot Entry Name | THNS2_HUMAN,THNS2_RAT |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000144115 |
Target Classification | N/A |
The target: THNSL2, gene name: THNSL2, also named as SOFAT, THS2, TSH2. This gene encodes a threonine synthase-like protein. A similar enzyme in mouse can catalyze the degradation of O-phospho-homoserine to a-ketobutyrate, phosphate, and ammonia. This protein also has phospho-lyase activity on both gamma and beta phosphorylated substrates. In mouse an alternatively spliced form of this protein has been shown to act as a cytokine and can induce the production of the inflammatory cytokine IL6 in osteoblasts. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.